Abpro Holdings (ABPO) EBT (2022 - 2026)
Abpro Holdings' (ABPO) quarterly EBT came in at -$983000.0 in Q1 2026, up 73.27% YoY from -$567335.0 in Q1 2025, and up 49.46% on a QoQ basis from -$1.9 million in Q4 2025.
Abpro Holdings (ABPO) EBT (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of EBT data on file, last reported at -$983000.0 in Q1 2026.
- Quarterly EBT rose 73.27% year-over-year to -$983000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (up 6.08% YoY) and the FY2025 annual result came in at -$42.1 million, up 2.49% from the prior year.
- EBT grew to -$983000.0 in Q1 2026, from -$1.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of $2.8 million in Q1 2023 to a low of -$3.7 million in Q1 2025.
- A 5-year average of -$563757.5 and a median of -$312678.0 in 2024 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT surged 688.16% — and 2024, when it tumbled 4084.33%.
- Tracing ABPO's EBT over 5 years: stood at $2.0 million in 2022, then plunged by 96.15% to $76575.0 in 2023, then plunged by 4084.33% to -$3.1 million in 2024, then jumped by 36.25% to -$1.9 million in 2025, then soared by 49.46% to -$983000.0 in 2026.
- The last three EBT figures came in at -$983000.0 (Q1 2026), -$1.9 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 81.49 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -983,000.00 |
| Dec 31, 2025 | -1.95 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Mar 31, 2025 | -3.68 Mn |
| Dec 31, 2024 | -3.05 Mn |
| Sep 30, 2024 | -307,446.00 |
| Jun 30, 2024 | -312,678.00 |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | 76,575.00 |
| Sep 30, 2023 | 51,375.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 2.75 Mn |
| Dec 31, 2022 | 1.99 Mn |
| Sep 30, 2022 | 939,455.00 |
| Jun 30, 2022 | -190,500.00 |
| Mar 31, 2022 | -1.03 Mn |